Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lush

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
European Journal of Epidemiology|October 3, 2023
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancerKatharina Wichert, Reiner Hoppe, Katja Ickstadt, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Database : the Journal of Biological Databases and Curation|September 21, 2011
BioMart Central Portal: an open database network for the biological communityJonathan M Guberman, J Ai, O Arnaiz, et al.
Nature Genetics|September 26, 2023
Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer riskNaomi Wilcox, Martine Dumont, Anna González-Neira, et al.
Nature Genetics|August 17, 2023
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer riskNaomi Wilcox, Martine Dumont, Anna González-Neira, et al.
Cancer Research Communications|October 28, 2022
A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 womenXiaoliang Wang, Hongjie Chen, Pooja Middha Kapoor, et al.
NPJ Breast Cancer|February 19, 2025
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancerReiner Hoppe, Stefan Winter, Wing-Yee Lo, et al.
Cancers|July 14, 2023
Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer CasesGisella Figlioli, Amandine Billaud, Qin Wang, et al.
Scientific Reports|April 14, 2022
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 womenXiaoliang Wang, Pooja Middha Kapoor, Paul L Auer, et al.
European Journal of Human Genetics : EJHG|January 27, 2023
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European womenGisella Figlioli, Amandine Billaud, Thomas U Ahearn, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
European Journal of Epidemiology|October 3, 2023
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancerKatharina Wichert, Reiner Hoppe, Katja Ickstadt, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Database : the Journal of Biological Databases and Curation|September 21, 2011
BioMart Central Portal: an open database network for the biological communityJonathan M Guberman, J Ai, O Arnaiz, et al.
Nature Genetics|September 26, 2023
Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer riskNaomi Wilcox, Martine Dumont, Anna González-Neira, et al.
Nature Genetics|August 17, 2023
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer riskNaomi Wilcox, Martine Dumont, Anna González-Neira, et al.
Cancer Research Communications|October 28, 2022
A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 womenXiaoliang Wang, Hongjie Chen, Pooja Middha Kapoor, et al.
NPJ Breast Cancer|February 19, 2025
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancerReiner Hoppe, Stefan Winter, Wing-Yee Lo, et al.
Cancers|July 14, 2023
Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer CasesGisella Figlioli, Amandine Billaud, Qin Wang, et al.
Scientific Reports|April 14, 2022
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 womenXiaoliang Wang, Pooja Middha Kapoor, Paul L Auer, et al.
European Journal of Human Genetics : EJHG|January 27, 2023
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European womenGisella Figlioli, Amandine Billaud, Thomas U Ahearn, et al.
Pageof 5